Allulose Supplier Daesang Reports 450% North American Sales Jump, Plans Global Expansion
Korean biotech firm Daesang significantly scales its North American allulose operations, reporting a 450% sales increase in 2025 and announcing global expansion plans. This signals intensifying competition in the sugar reduction ingredient market and offers new supply chain options for manufacturers.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 19 October 2026
South Korean biotech company Daesang is aggressively expanding its allulose business in North America, reporting a 450% surge in 2025 sales compared to 2024. This growth, driven by increasing consumer demand for sugar reduction, positions Daesang as a formidable competitor in the low-calorie sweetener market. While the company did not specify whether the sales increase represents value or volume, it underscores significant market penetration since its North American entry in 2023.
Operating under its Sweevero brand, launched in 2024, Daesang is moving beyond basic allulose supply to offer integrated solutions. These include customised sweetener blends and taste modulation technologies, directly addressing formulator challenges in maintaining sensory profiles when reducing sugar. Hyo-hoon Lee, Head of Ingredient Marketing at Daesang, noted rising demand across various food categories due to heightened health awareness regarding sugar intake. Daesang currently services approximately 30 North American customers across applications including beverages, dairy, confectionery, nutrition, and sauces, according to Food Ingredients First.
Allulose, a rare sugar found naturally in small quantities, provides approximately 70% of sugar's sweetness with only about 10% of its caloric content. The move towards comprehensive sugar reduction solutions aligns with broader industry trends. Research from ADM and Ingredion highlights the importance of tailoring sweetness and texture profiles to specific consumer segments and market needs, rather than a universal sugar replacement. Innova Market Insights data reveals a 7% CAGR for reduced-sugar product launches between July 2021 and June 2026, with sauces and soups showing rapid growth, indicating widespread reformulation opportunities.
Daesang plans to extend its reach into major markets, including Canada, Latin America, Europe, Japan, and Southeast Asia, contingent on evolving regulatory frameworks. The company is exploring increased production capacity and a more regionally diversified supply network, including potential local manufacturing in key markets, leveraging its Gunsan facility in South Korea and its US subsidiary for current supply.
What this means for United Kingdom
UK manufacturers and brand owners should anticipate increased competition in the sugar reduction ingredient sector by late 2027, potentially influencing allulose pricing and availability. Daesang's stated intent to pursue European novel food registration for allulose indicates future market entry, creating an alternative supply channel to existing European providers. This offers opportunities for enhanced supply chain resilience and cost negotiation. Brand owners must proactively assess current formulations for competitive viability against products leveraging advanced taste modulation. Regulatory teams should monitor novel food approvals and prepare for potential increased consumer awareness regarding allulose as new entrants stimulate market growth, requiring clear labelling and marketing strategies.
Many leading brands in this category are manufactured in partnership with Supplement Factory.